021-51111890
购物车（）
sales@molnova.cn
Azide-PEG12-alcohol
CAS No. 1821464-55-4
Azide-PEG12-alcohol ( —— )
产品货号. M26889 CAS No. 1821464-55-4
Azide-PEG12-alcohol 是一种基于 PEG 的 PROTAC 连接体，可用于 PROTAC 的合成。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ￥275 | 有现货 |
|
| 25MG | ￥437 | 有现货 |
|
| 50MG | ￥632 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Azide-PEG12-alcohol
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Azide-PEG12-alcohol 是一种基于 PEG 的 PROTAC 连接体，可用于 PROTAC 的合成。
-
产品描述Azide-PEG12-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
体外实验PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体S. aureus
-
研究领域——
-
适应症——
化学信息
-
CAS Number1821464-55-4
-
分子量571.665
-
分子式C24H49N3O12
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCN=[N+]=[N-]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.SIERRA G, VERINGA HA. Effect of oxychlororaphin on the growth in vitro of Streptomyces species and some pathogenic fungi. Nature. 1958 Jul 26;182(4630):265.
产品手册
关联产品
-
2-(2-Phenylethyl)chr...
2-(2-苯乙基)色酮是从白木香中分离出来的天然产物。
-
Beta-Hydroxyisovaler...
3-Hydroxyisovaleric acid 是尿液中排泄的正常内源性代谢产物 (endogenous metabolite)。3-Hydroxyisovaleric acid 的尿排泄是生物素缺乏的早期和敏感指标。
-
pep2-SVKI
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD).
